Kaposi's sarcoma (KS)-associated herpesvirus (KSHV) is a gamma-2 gammaherpesvirus that was identified in 1994 to be the cause of AIDS-related KS (11), one of the most common malignancies within human immunodeficiency virus (HIV)-infected individuals. KSHV establishes a persistent infection within B cells (2,14) and is also associated with the malignant B cell disorders, multicentric Castleman's disease (MCD), and primary effusion lymphoma (PEL) (9, 48). Patients who develop MCD and PEL often have a poor outcome, especially if these B cell disorders develop before the introduction of highly active antiretroviral therapy (HAART) (7). Moreover, recent studies have documented an increase in KS within individuals on long-term therapy, despite maintenance of low HIV loads and high CD4 T cell numbers (31). These findings now suggest that the development of KSHV-associated diseases is dependent on other unidentified factors and not simply just immune suppression.Studying host-pathogen interactions during de novo KSHV infection and disease pathogenesis has been hindered by the scarcity of animal models that recapitulate the human disease (10, 16, 42). Rhesus macaque (RM) rhadinovirus (RRV) is a closely related gammaherpesvirus (1, 13, 15, 46) that naturally infects RMs and establishes latency within B cells (4). Moreover, RRV infection of RMs induces an acute hyperproliferation of B cells (17, 54) that often develops into diseases that resemble non-Hodgkin's lymphoma and MCD in immune-compromised animals (37). The striking similarities between KSHV-and RRV-associated pathologies (4,17,37,54), along with the nearly colinear genomic organization (1, 46), make RRV infection of RMs an ideal model for studying KSHV disease. Moreover, recent generation and characterization of a bacterial artificial chromosome (BAC) clone of RRV isolate 17577 (wild-type BAC-derived [WT BAC ] RRV 17577 ) (17) allow specific genes to be targeted for deletion to effectively address their roles during infection.KSHV and RRV encode a number of viral homologues of cellular genes involved in immune signaling, apoptosis, and cellular growth and differentiation. Accordingly, these viral homologues play critical roles in subverting the immune response (3). In particular, KSHV and RRV both encode a cluster of viral interferon ( (5, 6, 18-20, 24, 29, 52, 55). Furthermore, KSHV vIRF-1 displayed tumorigenic potential in NIH 3T3 cells and nude mice (20), and KSHV vIRF-1, -3, and -4 independently disrupt p53 function, inhibiting p53-induced apoptosis and/or cell cycle control (28,34,43,47). Additional antiapoptotic functions have also been attributed to KSHV vIRF-1 and vIRF-3. For example, KSHV vIRF-1 binds and sequesters the proapoptotic protein Bim, reducing levels of apoptosis (12), and RNA interference knockdown of KSHV vIRF-3 results in increased activity of effector caspases in KSHV-infected PEL cells (53). Collectively, these data illustrate the functional breadth and diversity of pathways/cellular functions that are targeted by the vIRFs, but these da...